AI Medical Technology's Dermalyser Gains CE Mark for Melanoma Detection
AI Medical Technology has received CE mark approval for Dermalyser, a smartphone-based melanoma detection tool, allowing its commercial launch across Europe.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
AI Medical Technology has received CE mark approval for Dermalyser, a smartphone-based melanoma detection tool, allowing its commercial launch across Europe.
Lunit will present 12 studies at the ASCO 2025 Annual Meeting, highlighting AI's role in precision oncology, including HER2 analysis in biliary tract cancer and PD-L1 evaluation in lung cancer.
MindHYVE.ai has partnered with Islamabad Diagnostic Centre to deploy AGI-powered diagnostic agents across Pakistan, enhancing clinical diagnostics with AI technology.
Perimeter Medical Imaging AI has partnered with Intermountain Health to study the benefits of using OCT and AI in reducing cancer reoperations, announced in a press release.
GATC Health Corp has published a paper detailing how its AI-driven Multiomics Advanced Technology platform enhances drug discovery by improving efficiency and reducing animal testing.
The American Society of Clinical Oncology (ASCO) and Google Cloud have announced a collaboration to launch an AI-based tool for accessing ASCO's clinical guidelines, enhancing oncology professionals' decision-making capabilities.
Astellas Pharma and MBC BioLabs have awarded the 2025 Astellas Future Innovator Prize to DeepSeq.AI and Serna Bio, granting them access to advanced lab facilities and expertise to further their research.
Recovery.com has acquired RedFox AI to enhance its AI capabilities in mental health and addiction treatment, announced in a press release.
RamSoft and Therapixel have announced a partnership to integrate AI-powered breast imaging solutions into RamSoft's platforms, enhancing cancer detection and radiologist workflows.
Fine-tuned large language models (LLMs) have shown significant potential in improving error detection in radiology reports, according to a recent study published in Radiology. The study highlights the effectiveness of models like GPT-4 and Llama-3-70B-Instruct in identifying errors in chest x-ray reports.
ProgenyHealth has announced a significant growth investment from Cressey & Company and existing investor Sunstone Partners to expand its maternity and NICU care services.
Rad AI has announced an additional $8 million investment from four major health systems, bringing its Series C funding to $68 million.
PHASE Scientific has raised $34 million in a Series A funding round to advance its urine-based diagnostic technology for early disease detection, announced in a press release.
SIME Diagnostics has announced the results of a clinical study on its AI-powered Lung Maturity Test for late-preterm newborns, conducted in collaboration with Mayo Clinic.
UCB and Domino Data Lab have announced a collaboration to modernize the Statistical Computing Environment for life sciences, integrating advanced cloud technologies and data science tools.
Lunit has achieved a significant milestone by surpassing one million mammograms in the U.S., a year after acquiring Volpara Health, according to a press release.
Cortechs.ai and ALZ-NET have announced a strategic collaboration to enhance Alzheimer's disease care using AI-driven imaging technology.
IMVARIA has presented its AI-powered diagnostic service, Fibresolve, at the ATS 2025 Conference, highlighting its use in diagnosing lung diseases like Idiopathic Pulmonary Fibrosis.
Royal Philips' Future Health Index 2025 report emphasizes AI's transformative potential in healthcare, while highlighting trust gaps among clinicians and patients as a barrier to adoption.
Oracle, Cleveland Clinic, and G42 have announced a strategic partnership to develop an AI-based global healthcare delivery platform, aiming to enhance patient care and public health management.